Tertiary Patents on Drugs Approved by the FDA

This cohort study analyzes patent protection on small-molecule drugs approved by the US Food and Drug Administration from 1986 to 2023 with 1 or more tertiary patents.

from JAMA Health Forum New Online https://ift.tt/aCvdKVg